Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astria Therapeutics (ATXS) Assets: 2017-2018

Historic Assets for Astria Therapeutics (ATXS) over the last 2 years, with Dec 2018 value amounting to $39.2 million.

  • Astria Therapeutics' Assets fell 1.94% to $43.8 million in Q3 2019 from the same period last year, while for Sep 2019 it was $43.8 million, marking a year-over-year decrease of 1.94%. This contributed to the annual value of $39.2 million for FY2018, which is 118.86% up from last year.
  • According to the latest figures from FY2018, Astria Therapeutics' Assets is $39.2 million, which was up 118.86% from $17.9 million recorded in FY2017.
  • Over the past 5 years, Astria Therapeutics' Assets peaked at $39.2 million during FY2018, and registered a low of $17.9 million during FY2017.
  • In the last 2 years, Astria Therapeutics' Assets had a median value of $28.5 million in 2017 and averaged $28.5 million.
  • Data for Astria Therapeutics' Assets shows a peak YoY surged of 118.86% (in 2018) over the last 5 years.
  • Yearly analysis of 2 years shows Astria Therapeutics' Assets stood at $17.9 million in 2017, then soared by 118.86% to $39.2 million in 2018.